Brokerages expect Novadaq Technologies Inc (NASDAQ:NVDQ) (TSE:NDQ) to announce earnings per share of ($0.21) for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Novadaq Technologies’ earnings, with the highest EPS estimate coming in at ($0.18) and the lowest estimate coming in at ($0.23). Novadaq Technologies reported earnings per share of ($0.19) in the same quarter last year, which suggests a negative year-over-year growth rate of 10.5%. The business is scheduled to announce its next earnings report on Wednesday, November 1st.

On average, analysts expect that Novadaq Technologies will report full year earnings of ($0.87) per share for the current year, with EPS estimates ranging from ($0.94) to ($0.77). For the next year, analysts expect that the business will post earnings of ($0.71) per share, with EPS estimates ranging from ($0.94) to ($0.49). Zacks’ earnings per share calculations are an average based on a survey of analysts that cover Novadaq Technologies.

Several research analysts have weighed in on the company. Zacks Investment Research raised Novadaq Technologies from a “sell” rating to a “hold” rating in a research report on Friday, August 18th. Royal Bank Of Canada lowered Novadaq Technologies from an “outperform” rating to a “sector perform” rating and lowered their price target for the stock from $12.00 to $11.75 in a research report on Thursday, July 13th. Northland Securities reaffirmed a “hold” rating and set a $11.75 price target on shares of Novadaq Technologies in a research report on Monday, August 14th. JMP Securities reaffirmed a “market perform” rating on shares of Novadaq Technologies in a research report on Thursday, July 13th. Finally, First Analysis lowered Novadaq Technologies from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company’s stock. Novadaq Technologies presently has a consensus rating of “Hold” and a consensus price target of $11.86.

COPYRIGHT VIOLATION NOTICE: “-$0.21 Earnings Per Share Expected for Novadaq Technologies Inc (NVDQ) This Quarter” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.thecerbatgem.com/2017/08/31/0-21-earnings-per-share-expected-for-novadaq-technologies-inc-nvdq-this-quarter.html.

Shares of Novadaq Technologies (NVDQ) remained flat at $11.75 during midday trading on Friday. The company had a trading volume of 395,280 shares. The company’s market capitalization is $679.41 million. The stock has a 50 day moving average of $11.68 and a 200-day moving average of $8.94. Novadaq Technologies has a 1-year low of $5.84 and a 1-year high of $12.74.

Hedge funds and other institutional investors have recently modified their holdings of the company. JPMorgan Chase & Co. increased its position in shares of Novadaq Technologies by 4.8% in the second quarter. JPMorgan Chase & Co. now owns 5,308,769 shares of the medical research company’s stock valued at $62,219,000 after buying an additional 243,261 shares in the last quarter. FMR LLC increased its stake in Novadaq Technologies by 30.5% in the first quarter. FMR LLC now owns 3,107,271 shares of the medical research company’s stock valued at $24,206,000 after buying an additional 726,288 shares during the period. Janus Henderson Group PLC purchased a new stake in Novadaq Technologies during the second quarter valued at about $32,663,000. Elk Creek Partners LLC increased its stake in Novadaq Technologies by 6.9% in the first quarter. Elk Creek Partners LLC now owns 2,703,682 shares of the medical research company’s stock valued at $21,062,000 after buying an additional 174,499 shares during the period. Finally, Clearbridge Investments LLC increased its stake in Novadaq Technologies by 0.4% in the first quarter. Clearbridge Investments LLC now owns 2,554,843 shares of the medical research company’s stock valued at $19,902,000 after buying an additional 9,371 shares during the period. Institutional investors own 75.38% of the company’s stock.

About Novadaq Technologies

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Get a free copy of the Zacks research report on Novadaq Technologies (NVDQ)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Stock Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related stocks with our FREE daily email newsletter.